Impact of smoking in patients with suspected coronary artery disease in the randomised DISCHARGE trial
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, pragmatická klinická studie
PubMed
37991508
DOI
10.1007/s00330-023-10355-2
PII: 10.1007/s00330-023-10355-2
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiac catheterisation, Cardiac imaging techniques, Cardiovascular disease, Cigarette smoking, Computed tomography angiography,
- MeSH
- koronární angiografie * metody MeSH
- kouření * škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- nemoci koronárních tepen * diagnostické zobrazování komplikace MeSH
- počítačová rentgenová tomografie * metody MeSH
- propuštění pacienta MeSH
- prospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pragmatická klinická studie MeSH
OBJECTIVES: To investigate if the effect of cardiac computed tomography (CT) vs. invasive coronary angiography (ICA) on cardiovascular events differs based on smoking status. MATERIALS AND METHODS: This pre-specified subgroup analysis of the pragmatic, prospective, multicentre, randomised DISCHARGE trial (NCT02400229) involved 3561 patients with suspected coronary artery disease (CAD). The primary endpoint was major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, or stroke). Secondary endpoints included an expanded MACE composite (MACE, transient ischaemic attack, or major procedure-related complications). RESULTS: Of 3445 randomised patients with smoking data (mean age 59.1 years + / - 9.7, 1151 men), at 3.5-year follow-up, the effect of CT vs. ICA on MACE was consistent across smoking groups (p for interaction = 0.98). The percutaneous coronary intervention rate was significantly lower with a CT-first strategy in smokers and former smokers (p = 0.01 for both). A CT-first strategy reduced the hazard of major procedure-related complications (HR: 0.21, 95% CI: 0.03, 0.81; p = 0.045) across smoking groups. In current smokers, the expanded MACE composite was lower in the CT- compared to the ICA-first strategy (2.3% (8) vs 6.0% (18), HR: 0.38; 95% CI: 0.17, 0.88). The rate of non-obstructive CAD was significantly higher in all three smoking groups in the CT-first strategy. CONCLUSION: For patients with stable chest pain referred for ICA, the clinical outcomes of CT were consistent across smoking status. The CT-first approach led to a higher detection rate of non-obstructive CAD and fewer major procedure-related complications in smokers. CLINICAL RELEVANCE STATEMENT: This pre-specified sub-analysis of the DISCHARGE trial confirms that a CT-first strategy in patients with stable chest pain referred for invasive coronary angiography with an intermediate pre-test probability of coronary artery disease is as effective as and safer than invasive coronary angiography, irrespective of smoking status. TRIAL REGISTRATION: ClinicalTrials.gov NCT02400229. KEY POINTS: • No randomised studies have assessed smoking status on CT effectiveness in symptomatic patients referred for invasive coronary angiography. • A CT-first strategy results in comparable adverse events, fewer complications, and increased coronary artery disease detection, irrespective of smoking status. • A CT-first strategy is safe and effective for stable chest pain patients with intermediate pre-test probability for CAD, including never smokers.
Administrative Centre Health Care District of Southwestern Finland Turku Finland
Bavarian Cancer Registry Bavarian Health and Food Safety Authority Munich Germany
Berlin Institute of Health at Charité Universitätsmedizin Berlin Berlin Germany
Berlin University Alliance Berlin Germany
Centro de Investigacion Biomedica en Red Madrid Spain
County Clinical Emergency Hospital Targu Mures Targu Mures Romania
Department of Cardiology Aintree University Hospital Liverpool UK
Department of Cardiology Alb Fils Kliniken Göppingen Germany
Department of Cardiology Basurto Hospital Bilbao Spain
Department of Cardiology Centro Hospitalar de Vila Nova de Gaia Espinho Vila Nova de Gaia Portugal
Department of Cardiology Copenhagen University Hospital Amager and Hvidovre Hvidovre Denmark
Department of Cardiology Herlev Gentofte Hospital Hellerup Denmark
Department of Cardiology Hospital of Lithuanian University of Health Sciences Kaunas Lithuania
Department of Cardiology Institute for Cardiovascular Diseases of Vojvodina Novi Sad Serbia
Department of Cardiology Internal Medicine Clinic Clinical Hospital Center Zemun Belgrade Serbia
Department of Cardiology Liverpool University Hospital NHS FT Liverpool UK
Department of Cardiology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania
Department of Cardiology Motol University Hospital Prague Czech Republic
Department of Cardiology Nordsjællands Hospital University of Copenhagen Copenhagen Denmark
Department of Cardiology Paul Stradins Clinical University Hospital Riga Latvia
Department of Cardiology Provincial Specialist Hospital in Wroclaw Wroclaw Poland
Department of Cardiology Southeastern Health and Social Care Trust Belfast UK
Department of Cardiology St Vincent's University Hospital Dublin Ireland
Department of Cardiology University of Leipzig Heart Centre Leipzig Germany
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Radiological Sciences Sapienza University of Rome Rome Italy
Department of Radiology Aintree University Hospital Liverpool UK
Department of Radiology and Neuroradiology SS Annunziata Hospital Taranto Italy
Department of Radiology Basurto Hospital Bilbao Spain
Department of Radiology Innsbruck Medical University Innsbruck Austria
Department of Radiology Medical Imaging Center Semmelweis University Budapest Hungary
Department of Radiology Motol University Hospital Prague Czech Republic
Department of Radiology Provincial Specialist Hospital in Wroclaw Wroclaw Poland
Department of Radiology St Vincent's University Hospital Dublin Ireland
Department of Radiology University of Cagliari Cagliari CA Italy
Department of Radiology University of Leipzig Heart Centre Leipzig Germany
Deutsches Herzzentrum Der Charité Berlin Germany
Deutsches Herzzentrum Der Charité Partner Site Berlin Berlin Germany
Deutsches Herzzentrum Der Charité Partner Site Berlin Germany
Duke Clinical Research Institute Duke University School of Medicine Durham NC USA
Edge Hill University Ormskirk UK
Faculty of Medicine University of Belgrade Belgrade Serbia
Faculty of Medicine University of Latvia Riga Latvia
Faculty of Medicine University of Novi Sad Novi Sad Serbia
Golden Jubilee National Hospital Clydebank UK
Heart and Vascular Center Semmelweis University Budapest Hungary
Heart Center Turku University Hospital and University of Turku Turku Finland
Liverpool Centre for Cardiovascular Studies University of Liverpool Liverpool UK
National Institute of Cardiology Warsaw Poland
School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK
School of Medicine University College Dublin Dublin Ireland
Turku PET Centre Turku University Hospital and University of Turku Turku Finland
Zobrazit více v PubMed
McEvoy JW, Blaha MJ, Rivera JJ et al (2012) Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc Imaging 5:1037–1045 PubMed DOI PMC
Shaw LJ, Raggi P, Callister TQ, Berman DS (2006) Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J 27:968–975 PubMed DOI
Musallam KM, Rosendaal FR, Zaatari G et al (2013) Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg 148:755–762 PubMed DOI
Suskin N, Sheth T, Negassa A, Yusuf S (2001) Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 37:1677–1682 PubMed DOI
Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR Jr (1997) Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 336:755–761 PubMed DOI
Vlietstra RE, Kronmal RA, Oberman A, Frye RL, Killip T 3rd (1986) Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA 255:1023–1027 PubMed
Haase R, Schlattmann P, Gueret P et al (2019) Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. BMJ 365:l1945 PubMed DOI PMC
Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407–477 PubMed DOI
Gulati M, Levy PD, Mukherjee D et al (2021) 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 78:2218–2261 PubMed DOI
Hoffmann U, Ferencik M, Udelson JE et al (2017) Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation 135:2320–2332 PubMed DOI PMC
Newby DE, Adamson PD, Berry C et al (2018) SCOT-HEART Investigators. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 379:924–933 PubMed DOI
Maurovich-Horvat P, Bosserdt M, Kofoed KF et al (2022) DISCHARGE Trial Group. CT or invasive coronary angiography in stable chest pain. N Engl J Med 386:1591–1602 PubMed DOI
Salehi N, Janjani P, Tadbiri H, Rozbahani M, Jalilian M (2021) Effect of cigarette smoking on coronary arteries and pattern and severity of coronary artery disease: a review. J Int Med Res 49:3000605211059893 PubMed DOI
Gambardella J, Sardu C, Sacra C, Del Giudice C, Santulli G (2017) Quit smoking to outsmart atherogenesis: molecular mechanisms underlying clinical evidence. Atherosclerosis 257:242–245 PubMed DOI
Nakanishi R, Berman DS, Budoff MJ et al (2015) Current but not past smoking increases the risk of cardiac events: insights from coronary computed tomographic angiography. Eur Heart J 36:1031–1040 PubMed DOI PMC
Yi M, Chun EJ, Lee MS, Lee J, Choi SI (2015) Coronary CT angiography findings based on smoking status: do ex-smokers and never-smokers share a low probability of developing coronary atherosclerosis? Int J Cardiovasc Imaging 31(2):169–176 PubMed DOI
Shahim B, Redfors B, Chen S et al (2020) Outcomes after left main coronary artery revascularization by percutaneous coronary intervention or coronary artery bypass grafting according to smoking status. Am J Cardiol 127:16–24 PubMed DOI
Takahashi K, Thuijs D, Gao C et al (2022) Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization. Eur J Prev Cardiol 29:312–320 PubMed DOI
Min JK, Dunning A, Lin FY et al (2011) Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 58:849–860 PubMed DOI
Min JK, Shaw LJ, Devereux RB et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50:1161–1170 PubMed DOI
Napp AE, Haase R, Laule M et al (2017) DISCHARGE Trial Group. Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial. Eur Radiol 27:2957–2968 PubMed DOI
Moher D, Schulz KF, Altman D (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. JAMA 285:1987–1991 PubMed DOI
Cook DG, Shaper AG, MacFarlane PW (1989) Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology. Int J Epidemiol 18:607–613 PubMed DOI
Schuetz GM, Schlattmann P, Achenbach S et al (2013) Individual patient data meta-analysis for the clinical assessment of coronary computed tomography angiography: protocol of the Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT). Syst Rev 2:13 PubMed DOI PMC
Windecker S, Kolh P, Alfonso F et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619 PubMed DOI
Wang TW, Asman K, Gentzke AS et al (2018) Tobacco product use among adults - United States, 2017. MMWR Morb Mortal Wkly Rep 67:1225–1232 PubMed DOI PMC
Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42:3227–3337 PubMed DOI
Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66:403–469 PubMed DOI
Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581–1598 PubMed DOI
Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:2064–2089 PubMed DOI PMC
Jang JJ, Bhapkar M, Coles A et al (2019) Predictive model for high-risk coronary artery disease. Circ Cardiovasc Imaging 12:e007940 PubMed DOI PMC
Kolossváry M, Szilveszter B, Édes IF et al (2016) Comparison of quantity of coronary atherosclerotic plaques detected by computed tomography versus angiography. Am J Cardiol 117:1863–1867 PubMed DOI
Wieske V, Walther M, Dubourg B et al (2022) Computed tomography angiography versus Agatston score for diagnosis of coronary artery disease in patients with stable chest pain: individual patient data meta-analysis of the international COME-CCT Consortium. Eur Radiol 32:5233–5245 PubMed DOI PMC
Mascalchi M, Romei C, Marzi C et al (2023) Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial. Eur Radiol 33:3115–3123 PubMed DOI PMC
Knol WG, den Harder AM, de Heer LM et al (2023) Incidental findings on routine preoperative noncontrast chest computed tomography and chest radiography prior to cardiac surgery in the multicenter randomised controlled CRICKET study. Eur Radiol 33:294–301 PubMed DOI
Cheezum MK, Kim A, Bittencourt MS et al (2017) Association of tobacco use and cessation with coronary atherosclerosis. Atherosclerosis 257:201–207 PubMed DOI
Yan RT, Miller JM, Rochitte CE et al (2013) Predictors of inaccurate coronary arterial stenosis assessment by CT angiography. JACC Cardiovasc Imaging 6:963–972 PubMed DOI PMC
ClinicalTrials.gov
NCT02400229